<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Protokinetix Inc — News on 6ix</title>
    <link>https://6ix.com/company/protokinetix-inc</link>
    <description>Latest news and press releases for Protokinetix Inc on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Tue, 06 Jun 2023 12:31:14 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/protokinetix-inc" rel="self" type="application/rss+xml" />
    <image>
      <url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835adb178dffbe2df10e87e.webp</url>
      <title>Protokinetix Inc</title>
      <link>https://6ix.com/company/protokinetix-inc</link>
    </image>
    <item>
      <title>Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication</title>
      <link>https://6ix.com/company/protokinetix-inc/news/research-paper-incorporating-protokinetix-aagpr-submitted-to-scientific-journal-for-publication</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/research-paper-incorporating-protokinetix-aagpr-submitted-to-scientific-journal-for-publication</guid>
      <pubDate>Tue, 06 Jun 2023 12:31:14 GMT</pubDate>
      <description>Research Paper Incorporating ProtoKinetix AAGP® Submitted to Scientific Journal for Publication.</description>
    </item>
    <item>
      <title>ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants</title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-successfully-completes-phase-1-clinical-trials-for-the-treatment-of-type-1-diabetes-in-islet-cell-transplants</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-successfully-completes-phase-1-clinical-trials-for-the-treatment-of-type-1-diabetes-in-islet-cell-transplants</guid>
      <pubDate>Wed, 20 Jul 2022 12:31:40 GMT</pubDate>
      <description>ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants.</description>
    </item>
    <item>
      <title>ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only</title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-announces-annual-general-stockholder-meeting-will-be-held-virtually-only</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-announces-annual-general-stockholder-meeting-will-be-held-virtually-only</guid>
      <pubDate>Fri, 14 Jan 2022 17:16:10 GMT</pubDate>
      <description>ProtoKinetix Announces Annual General Stockholder Meeting Will Be Held Virtually Only.</description>
    </item>
    <item>
      <title>ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease</title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-announces-selection-of-aagpr-candidate-formulations-for-treatment-of-dry-eye-disease</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-announces-selection-of-aagpr-candidate-formulations-for-treatment-of-dry-eye-disease</guid>
      <pubDate>Tue, 23 Nov 2021 12:04:09 GMT</pubDate>
      <description>ProtoKinetix Announces Selection of AAGP® Candidate Formulations for Treatment of Dry Eye Disease.</description>
    </item>
    <item>
      <title>ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions</title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-and-iqvia-partner-to-support-development-of-aagpr-product-in-the-treatment-of-ocular-conditions</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-and-iqvia-partner-to-support-development-of-aagpr-product-in-the-treatment-of-ocular-conditions</guid>
      <pubDate>Wed, 12 May 2021 12:05:42 GMT</pubDate>
      <description>ProtoKinetix and IQVIA Partner to Support Development of AAGP® Product in the Treatment of Ocular Conditions.</description>
    </item>
    <item>
      <title>ProtoKinetix Announces the Resumption of Phase 1b Clinical Trials for the use of AAGP® Treated Islet Cells in the Treatment of Type 1 Diabetes</title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-announces-the-resumption-of-phase-1b-clinical-trials-for-the-use-of-aagpr-treated-islet-cells-in-the-treatment-of-type-1-diabetes</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-announces-the-resumption-of-phase-1b-clinical-trials-for-the-use-of-aagpr-treated-islet-cells-in-the-treatment-of-type-1-diabetes</guid>
      <pubDate>Thu, 22 Apr 2021 12:10:41 GMT</pubDate>
      <description>ProtoKinetix Announces the Resumption of Phase 1b Clinical Trials for the use of AAGP® Treated Islet Cells in the Treatment of Type 1 Diabetes.</description>
    </item>
    <item>
      <title>ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease &amp; Ocular Inflammation with AAGP®</title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-engages-multi-national-partner-for-formulation-of-topical-drug-to-treat-dry-eye-disease-and-ocular-inflammation-with-aagpr</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-engages-multi-national-partner-for-formulation-of-topical-drug-to-treat-dry-eye-disease-and-ocular-inflammation-with-aagpr</guid>
      <pubDate>Wed, 14 Apr 2021 12:09:12 GMT</pubDate>
      <description>ProtoKinetix Engages Multi-National Partner for Formulation of Topical Drug to Treat Dry Eye Disease &amp; Ocular Inflammation with AAGP®.</description>
    </item>
    <item>
      <title>Journal of Tissue Engineering and Regenerative Medicine Publishes Peer Reviewed Research Paper Establishing ProtoKinetix AAGP® Enhanced Stem Cell Vision Restoration</title>
      <link>https://6ix.com/company/protokinetix-inc/news/journal-of-tissue-engineering-and-regenerative-medicine-publishes-peer-reviewed-research-paper-establishing-protokinetix-aagpr-enhanced-stem-cell-vision-restoration</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/journal-of-tissue-engineering-and-regenerative-medicine-publishes-peer-reviewed-research-paper-establishing-protokinetix-aagpr-enhanced-stem-cell-vision-restoration</guid>
      <pubDate>Wed, 07 Apr 2021 13:15:11 GMT</pubDate>
      <description>Journal of Tissue Engineering and Regenerative Medicine Publishes Peer Reviewed Research Paper Establishing ProtoKinetix AAGP® Enhanced Stem Cell Vision Restoration.</description>
    </item>
    <item>
      <title>Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision</title>
      <link>https://6ix.com/company/protokinetix-inc/news/research-paper-showing-protokinetix-aagpr-enhanced-stem-cell-derived-retina-precursor-cells-restoration-of-vision</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/research-paper-showing-protokinetix-aagpr-enhanced-stem-cell-derived-retina-precursor-cells-restoration-of-vision</guid>
      <pubDate>Tue, 24 Nov 2020 13:05:15 GMT</pubDate>
      <description>Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision.</description>
    </item>
    <item>
      <title>ProtoKinetix AAGP® Restores Vision in Blind Test Subjects</title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-aagpr-restores-vision-in-blind-test-subjects</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-aagpr-restores-vision-in-blind-test-subjects</guid>
      <pubDate>Tue, 15 Sep 2020 13:10:11 GMT</pubDate>
      <description>ProtoKinetix AAGP® Restores Vision in Blind Test Subjects.</description>
    </item>
    <item>
      <title>Ammendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials Have Been Approved by Health Canada</title>
      <link>https://6ix.com/company/protokinetix-inc/news/ammendments-to-protokinetix-aagpr-protocol-for-continuation-of-phase-1-human-trials-have-been-approved-by-health-canada</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/ammendments-to-protokinetix-aagpr-protocol-for-continuation-of-phase-1-human-trials-have-been-approved-by-health-canada</guid>
      <pubDate>Thu, 27 Aug 2020 13:02:42 GMT</pubDate>
      <description>Ammendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials Have Been Approved by Health Canada.</description>
    </item>
    <item>
      <title>ProtoKinetix AAGP® Moves to Whole Organ Transplantation Testing</title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-aagpr-moves-to-whole-organ-transplantation-testing</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-aagpr-moves-to-whole-organ-transplantation-testing</guid>
      <pubDate>Fri, 14 Aug 2020 13:24:11 GMT</pubDate>
      <description>ProtoKinetix AAGP® Moves to Whole Organ Transplantation Testing.</description>
    </item>
    <item>
      <title>Amendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials by the University of Alberta Submitted to Health Canada</title>
      <link>https://6ix.com/company/protokinetix-inc/news/amendments-to-protokinetix-aagpr-protocol-for-continuation-of-phase-1-human-trials-by-the-university-of-alberta-submitted-to-health-canada</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/amendments-to-protokinetix-aagpr-protocol-for-continuation-of-phase-1-human-trials-by-the-university-of-alberta-submitted-to-health-canada</guid>
      <pubDate>Mon, 13 Jul 2020 12:53:40 GMT</pubDate>
      <description>Amendments to ProtoKinetix AAGP® Protocol for Continuation of Phase 1 Human Trials by the University of Alberta Submitted to Health Canada.</description>
    </item>
    <item>
      <title>ProtoKinetix AAGP® Dry Eye Program Advancing</title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-aagpr-dry-eye-program-advancing</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-aagpr-dry-eye-program-advancing</guid>
      <pubDate>Tue, 07 Jul 2020 12:55:10 GMT</pubDate>
      <description>ProtoKinetix AAGP® Dry Eye Program Advancing.</description>
    </item>
    <item>
      <title>ProtoKinetix AAGP® Exhibits Efficacy and Safety in Model of Dry Eye Disease </title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-aagpr-exhibits-efficacy-and-safety-in-model-of-dry-eye-disease</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-aagpr-exhibits-efficacy-and-safety-in-model-of-dry-eye-disease</guid>
      <pubDate>Mon, 06 Apr 2020 12:50:10 GMT</pubDate>
      <description>ProtoKinetix AAGP® Exhibits Efficacy and Safety in Model of Dry Eye Disease.</description>
    </item>
    <item>
      <title>ProtoKinetix Ready to Ship AAGP® to the University of Alberta for the Continuation of Phase 1 Human Trials</title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-ready-to-ship-aagpr-to-the-university-of-alberta-for-the-continuation-of-phase-1-human-trials</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-ready-to-ship-aagpr-to-the-university-of-alberta-for-the-continuation-of-phase-1-human-trials</guid>
      <pubDate>Tue, 24 Mar 2020 12:48:39 GMT</pubDate>
      <description>ProtoKinetix Ready to Ship AAGP® to the University of Alberta for the Continuation of Phase 1 Human Trials.</description>
    </item>
    <item>
      <title>ProtoKinetix Files for Patent Protection for AAGP® to be Used in Dry Eye Disease </title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-files-for-patent-protection-for-aagpr-to-be-used-in-dry-eye-disease</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-files-for-patent-protection-for-aagpr-to-be-used-in-dry-eye-disease</guid>
      <pubDate>Thu, 19 Mar 2020 13:20:41 GMT</pubDate>
      <description>ProtoKinetix Files for Patent Protection for AAGP® to be Used in Dry Eye Disease.</description>
    </item>
    <item>
      <title>ProtoKinetix Announces Progress in the use of AAGP® in Cardiovascular Medicine</title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-announces-progress-in-the-use-of-aagpr-in-cardiovascular-medicine</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-announces-progress-in-the-use-of-aagpr-in-cardiovascular-medicine</guid>
      <pubDate>Wed, 19 Feb 2020 14:17:41 GMT</pubDate>
      <description>ProtoKinetix Announces Progress in the use of AAGP® in Cardiovascular Medicine.</description>
    </item>
    <item>
      <title>ProtoKinetix Files for Patent Protection for the Use of AAGP® in Transplant Medicine</title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-files-for-patent-protection-for-the-use-of-aagpr-in-transplant-medicine</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-files-for-patent-protection-for-the-use-of-aagpr-in-transplant-medicine</guid>
      <pubDate>Tue, 11 Feb 2020 13:23:39 GMT</pubDate>
      <description>ProtoKinetix Files for Patent Protection for the Use of AAGP® in Transplant Medicine.</description>
    </item>
    <item>
      <title>ProtoKinetix Takes Delivery of GMP AAGP® PKX-001 Dedicated for Phase 1 Trial</title>
      <link>https://6ix.com/company/protokinetix-inc/news/protokinetix-takes-delivery-of-gmp-aagpr-pkx-001-dedicated-for-phase-1-trial</link>
      <guid isPermaLink="true">https://6ix.com/company/protokinetix-inc/news/protokinetix-takes-delivery-of-gmp-aagpr-pkx-001-dedicated-for-phase-1-trial</guid>
      <pubDate>Fri, 24 Jan 2020 13:45:40 GMT</pubDate>
      <description>ProtoKinetix Takes Delivery of GMP AAGP® PKX-001 Dedicated for Phase 1 Trial.</description>
    </item>
  </channel>
</rss>